GENETIC TECHNOLOGIES LTD's ticker is GENE and the CUSIP is 37185R307. A total of 12 filers reported holding GENETIC TECHNOLOGIES LTD in Q1 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,846 | -8.9% | 87,656 | -0.8% | 0.00% | – |
| Q2 2023 | $73,406 | -38.0% | 88,356 | -13.4% | 0.00% | – |
| Q1 2023 | $118,412 | +153.7% | 102,079 | +103.4% | 0.00% | – |
| Q4 2022 | $46,667 | -24.7% | 50,179 | -4.1% | 0.00% | – |
| Q3 2022 | $62,000 | +1.6% | 52,329 | -0.4% | 0.00% | – |
| Q2 2022 | $61,000 | +13.0% | 52,529 | +93.6% | 0.00% | – |
| Q1 2022 | $54,000 | -51.8% | 27,129 | -54.5% | 0.00% | – |
| Q4 2021 | $112,000 | +20.4% | 59,621 | +98.0% | 0.00% | – |
| Q3 2021 | $93,000 | -64.4% | 30,113 | -51.1% | 0.00% | – |
| Q2 2021 | $261,000 | +2510.0% | 61,597 | +2414.2% | 0.00% | – |
| Q1 2021 | $10,000 | +100.0% | 2,450 | +88.5% | 0.00% | – |
| Q4 2020 | $5,000 | -86.1% | 1,300 | -87.6% | 0.00% | – |
| Q3 2020 | $36,000 | +227.3% | 10,447 | +109.1% | 0.00% | – |
| Q2 2020 | $11,000 | – | 4,997 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Scarborough Advisors, LLC | 10,638 | $8,113 | 0.00% |
| RHUMBLINE ADVISERS | 18,700 | $14,378 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MORGAN STANLEY | 87,656 | $66,846 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,844 | $12,083 | 0.00% |